Survival and toxicity following chemoradiation for carcinoma of the cervix - impact of multiple-phase treatment and shielding.
AffiliationHall Edwards Radiotherapy Research group, Cancer Centre, Queen Elizabeth Hospital, Birmingham, U.K.
MetadataShow full item record
AbstractWe report on outcomes and significant grade 3-4 late toxicities between January 1999 and October 2006 following introduction of multi-phase treatment and effect of shielding in treatment of cervical cancer with concurrent chemoradiation.
CitationSurvival and toxicity following chemoradiation for carcinoma of the cervix - impact of multiple-phase treatment and shielding. 2015, 35 (10):5567-74 Anticancer Res
- A Randomized Controlled Trial Comparing Clinical Outcomes and Toxicity of Lobaplatin- Versus Cisplatin-Based Concurrent Chemotherapy Plus Radiotherapy and High-Dose-Rate Brachytherapy for FIGO Stage II and III Cervical Cancer.
- Authors: Wang JQ, Wang T, Shi F, Yang YY, Su J, Chai YL, Liu Z
- Issue date: 2015
- Extended field radiotherapy with or without chemotherapy in patients with cervical cancer and positive para-aortic lymph nodes: a single institution retrospective review.
- Authors: Ng BH, Rozita A, Adlinda A, Lee WC, Wan Zamaniah W
- Issue date: 2015
- Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.
- Authors: Lorvidhaya V, Chitapanarux I, Sangruchi S, Lertsanguansinchai P, Kongthanarat Y, Tangkaratt S, Visetsiri E
- Issue date: 2003 Apr 1
- Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
- Authors: Lim A, Sia S
- Issue date: 2012 Mar 15
- Early stage cervical cancer with negative pelvic lymph nodes: pattern of failure and complication following radical hysterectomy and adjuvant radiotherapy.
- Authors: Chen SW, Liang JA, Yang SN, Lin FJ
- Issue date: 2004